HistoSonics治療原發性固體腎臟瘤的實驗性系統,使用組織脫水術
NCT:NCT05432232 · COMPLETED
廣告
NCT IDNCT05432232
狀態COMPLETED
開始日期2023-03-23
完成時間2025-06-06
SponsorHistoSonics, Inc. (INDUSTRY)
First posted
Last updated
簡要摘要
The purpose of this trial is to evaluate the technical success and safety profile of the HistoSonics Investigational System for the treatment of primary solid renal tumors.
官方來源
在 ClinicalTrials.gov 上查看 →資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。